CUBE vs EBS
CubeSmart (CUBE) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CUBE and EBS stock pages for the full models.
Not investment advice.